Congress leader Rahul Gandhi’s rally in the national capital on Thursday was canceled due to his poor health and medical advice. He was scheduled to hold the rally in Mustafabad in northeast ...
Congress leader Rahul Gandhi's mega rally at Mustafabad in the national capital on Thursday was cancelled due to his poor health and on medical advice, party's Delhi Chief Devender Yadav said.
INSIGNIA Financial’s shares hit a three-year high on Thursday (Jan 23), driven by a revised takeover offer of A$3.07 billion (S$2.6 billion) from US-based Bain Capital, matching the bid of rival CC ...
Insignia Financial has announced total quarterly net inflows of $2.3 billion as well as a third bid from Bain Capital. In its quarterly results for the three months to 31 December, it said total net ...
“Clearly, Insignia has shown a preference for CC Capital, because Bain will presumably pull the business apart, while CC Capital has indicated they’ll leave management to run the busines ...
Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...
The real estate arm of Boston’s Bain Capital LP’s and Atlanta’s Evergreen Medical Properties purchased the building at 2440 M St. NW in the District’s West End neighborhood for $45.5 ...
Addressing party leaders after the inauguration of the Congress' new headquarters at 9A, Kotla Road in the national capital, Rahul Gandhi said, "Do not think that we are fighting a fair fight.
Bain Capital, a global private investment firm, has proposed to acquire a significant minority shareholding in Dhoot Transmission Private Limited (DTPL) and its associate company, Dhoot Holdings ...
Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said, a transaction that could ...
Bain Capital is in talks to acquire Mitsubishi Chemical Group’s41880.31%increase; green up pointing triangle pharmaceutical business in a potential multibillion-dollar deal, a person familiar ...